--- type: "Topics" locale: "en" url: "https://longbridge.com/en/topics/100000000770792.md" description: "$Hims & Hers Health(HIMS.US) | Canaccord maintains ๐๐ฎ๐ฒ on ๐‡๐ข๐ฆ๐ฌ & ๐‡๐ž๐ซ๐ฌ, ๐ซ๐š๐ข๐ฌ๐ž๐ฌ ๐๐“ ๐ญ๐จ $๐Ÿ’๐ŸŽ ๐Ÿ๐ซ๐จ๐ฆ $๐Ÿ‘๐ŸAnalyst highlights a solid start to branded weight loss drugs, constructive sales data, and sees Hims as one of Novo's most "voluminous" partners." datetime: "2026-07-01T11:25:45.000Z" locales: - [en](https://longbridge.com/en/topics/100000000770792.md) - [zh-CN](https://longbridge.com/zh-CN/topics/100000000770792.md) - [zh-HK](https://longbridge.com/zh-HK/topics/100000000770792.md) author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)" generator: "portal-rs" --- # $Hims & Hers Health(HIMS.US) | Canaccord maintโ€ฆ ### Related Stocks - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [NVO.US](https://longbridge.com/en/quote/NVO.US.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**